A COMPOUND FOR THE TREATMENT OF HEPATITIS C

摘要

RSNdaThe present invention provides (1a 12b) 8 cyclohexyl 11 fluoro ((1 methylcyclopropyl)sulfonyl) 1a ((3 methyl 3 8 diazabicyclo[3.2.1]oct 8 yl)carbonyl) 1 1a 2 12b tetrahydrocyclopropa[]indolo[2 1 ][2]benzazepine 5 carboxamide (formula I) including pharmaceutically acceptable salts as well as compositions and methods of using the compound. The compound has activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.